Emodin can inhibit HCC growth by downregulating COX2 and activating PINK1/Parkin-mediated apoptosis (Chen et al., 2019; Hashemi Goradel et al., 2019; Hu et al., 2021). Here, PINK1 is linked to hepatocellular carcinoma.